Lung Cancer Trial, By Invitation NCT06028412 Sponsor: Xiaolong Yan, Dr. Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, By Invitation

NCT06028412
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged between 18 and 75 years old, of any gender.
  • People with a good general health and activity level, as measured by a standard performance score (ECOG score of 0–1) (confirm with trial site).
  • People whose lung lesion is suspected to be early-stage non-small cell lung cancer (Stage I, based on a standard cancer staging system) before surgery.
  • People whose tumor measures no more than 2.0 cm at its widest point, as shown on a detailed CT scan.
  • People whose CT scan shows a specific ratio of the solid part to the total size of the tumor, falling between 0.5 and 1.0 (confirm with trial site).
  • People with good lung function test results (FEV1 greater than 1.5 L or FEV1% at least 60%), meaning their lungs are strong enough to handle either of the two types of surgery being studied.
  • People who have no more than 3 lung nodules that need to be treated, and all nodules are on the same side of the chest.
  • People who are willing to sign a consent form and are able to attend all required study visits and follow the study plan.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People with high blood pressure or diabetes that is difficult to control.
  • People who are pregnant or breastfeeding.
  • People who have already received any cancer treatment before surgery, such as radiation, chemotherapy, targeted therapy, or immunotherapy.
  • People who have previously had lung surgery.
  • People who have interstitial pneumonia, pulmonary fibrosis, or severe emphysema (serious lung conditions).
  • People whose surgery requires a change in the planned surgical approach during the operation, such as switching to open chest surgery.
  • People with a serious mental illness.
  • People who have had a severe heart condition, heart failure, heart attack, or chest pain (angina) within the past 6 months.
  • People with an active bacterial or fungal infection that is difficult to control.
  • People who have taken part in another clinical trial within the 3 months before enrolling.
  • People whose tissue sample after surgery shows that the tumor is non-cancerous (benign).
  • People whose tissue sample after surgery shows a type of cancer that is not non-small cell lung cancer.
  • People whose non-small cell lung cancer is confirmed during surgery but is found to have spread to the lining of the lungs or to have fluid containing cancer cells around the lungs.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Xiaolong Yan, Dr.
Registry
ClinicalTrials.gov
Start date
1 January 2023
Est. completion
31 December 2029

Where this trial is recruiting

🇨🇳 China

Primary endpoints

DFS(Disease-free survival)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov